| Literature DB >> 32095375 |
Tatyana Ponomareva1, Dmitrii Sliadovskii1, Maria Timchenko1, Maxim Molchanov2, Alexander Timchenko3, Evgeny Sogorin1.
Abstract
In this study, several methods were used to analyze the hydrolysis of hyaluronic acid (HA)-based cosmetic fillers by the hepatopancreas homogenate of the Red king crab. The results show that the homogenate and commercially available hyaluronidases have similar hydrolysis activities on the fillers. Atomic force microscopy images reveal that the HA fillers consist mainly of spherical-like particles, which are converted into filamentous structures as a result of hydrolysis by the Red king crab hepatopancreas homogenate. Turbidimetric analysis of the hydrolysis process shows that HA aggregation with acidic albumin exhibits a bell-shaped dependence on reaction time. Analysis of the hydrolysis process by nuclear magnetic resonance shows that HA degradation lasts several days. The maximum rate of the reaction is detected in the 1st h of incubation. The data confirm that the purified homogenate of the Red king crab hepatopancreas exerts hyaluronidase activity on HA-based cosmetic fillers; therefore, it may be considered as a potential therapeutic agent for treating filler complications.Entities:
Keywords: Atomic force microscopy; Hepatopancreas; Hyaluronic acid; Hyaluronidase; Hyaluronidase activity; Nuclear magnetic resonance; Red king crab; Treating filler complications; Turbidimetric method
Year: 2020 PMID: 32095375 PMCID: PMC7023832 DOI: 10.7717/peerj.8579
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Turbidimetric analysis of HA from rooster comb, Revofil Ultra, Hyaluform and Teosyal Ultra fillers: (A) the dependence of optical density on the concentration of HA in rooster comb, Revofil Ultra, Hyaluform and Teosyal Ultra in turbidimetric analysis; (B) HA from rooster comb during hydrolysis by the HPC homogenate in turbidimetric analysis; (C) kinetics of the hydrolysis of HA from Revofil Ultra filler using the HPC homogenate in triplicate; (D) kinetics of the hydrolysis of HA from the Hyaluform filler using commercially available hyaluronidases and the HPC homogenate; (E) kinetics of the hydrolysis of HA from the Revofil Ultra filler using three different concentrations of the HPC homogenate protein; and (F) kinetics of the hydrolysis of HA from the Hyaluform filler using the HPC homogenate and its decontaminated sample (“decont. HPC”).
Figure 2AFM images (obtained in tapping mode) of the Hyaluform HA-based filler: (A) 50 × 50 μm field; (B) 1.4 × 1.4 μm field.
Figure 3AFM images (in tapping mode) of the hydrolysates of the Hyaluform HA-based filler: (A) 5 min, (B) 40 min and (C) 120 min of HA hydrolysis with the HPC homogenate.
Figure 41H-NMR spectra of the Hyaluform filler and its hydrolysis products after treatment by purified HPC homogenate.
The black curve represents the Hyaluform filler, and the red curve represents the hydrolysis products after 5 days of incubation.
Figure 5Hydrolysis of Hyaluform HA by purified HPC homogenate: (A) changes in the 1H signal of the N-acetyl-d-glucosamine acetyl group of HA chains in 1H-NMR spectra; (B) accumulation kinetics of the 1H signal of the N-acetyl-d-glucosamine acetyl group of HA chains (integral under the peaks).
The green marks represent the signal from the flexible part of the HA chains; the yellow marks represent the signal from the compact part of the HA chains; and the blue marks represent the total signals from both the flexible and compact parts of the HA chains.